01
Growth Capital
Growth capital for innovative, high-growth technology companies. We back proven teams with expanding markets, working alongside portfolio-company executives and co-investors as long-term, supportive partners.
Strategy
Patient capital, flexibly structured.
We invest $3M–$12M in established, high-growth companies — pairing a 30-plus-year legacy of supportive, collaborative partnership with more than 50 years of combined investing experience.
What we do
Three ways we put capital to work.
Every structure is tailored to the company's plan — capital that funds growth without forcing founders to give up control.
02
Structured Debt
Flexible structures tailored to each company's plan: senior debt, subordinated debt with warrants, preferred stock, and minority common equity. Capital that funds growth without forcing founders to give up control.
03
Stifel North Atlantic AM-Forward Fund
Long-term patient capital for established U.S. aerospace and defense manufacturers — Tier 2, 3, and 4 suppliers — expanding additive and advanced manufacturing capability, via senior debt, subordinated debt, warrants, and minority equity.
How we invest
Growth without loss of control.
North Atlantic Capital provides growth capital and structured debt to proven, high-growth technology companies. Rather than force a binary equity round, we build flexible structures — senior debt, subordinated debt with warrants, preferred stock, and minority common equity — sized to each company's plan.
Typical investments run $3M to $12M. We work alongside portfolio-company executives and co-investors as long-term, supportive partners — a posture the firm has held since 1986.
Through the Stifel North Atlantic AM-Forward Fund, we extend that same patient-capital approach to America's advanced-manufacturing supply chain: established U.S. aerospace and defense manufacturers — Tier 2, 3, and 4 suppliers — expanding additive and advanced manufacturing capability.